Literature DB >> 2733064

[The ocular fundus findings in dengue fever].

K H Wen, M M Sheu, C B Chung, H Z Wang, C W Chen.   

Abstract

From September to December of 1988, 24 cases of clinical diagnosed dengue fever accompanied by visual disturbances were studied. A detailed history and a detailed ocular examination including visual acuity, slit lamp examination, fundus examination through dilated pupil and fluorescein angiography were conducted. In some cases, Amsler grid, visual field, visual evoked potential and color vision test were also evaluated. The chief complaints of these 24 patients were blurred vision, central scotoma, floaters, photophobia and halo vision. The intervals between onset of fever and awareness of blurred vision were 2 to 15 days with an average of 7.26 days. The ocular fundus changes included macular hemorrhage, retinal hemorrhage, maculopathy, Roth's spot, diffuse retinal edema, peripapillary hemorrhage vitreous cells and blurring optic disc. The fluorescein angiographic findings included poor choroidal flushing, delayed disc filling, disc extravasation, block fluorescence, capillary obliteration, non filling of macular network, capillary leakage and window defect. Seventeen cases (30 eyes) were followed-up for 2 weeks to 3 months. Visual recovery was good in most of the cases. However, 2 cases (4 eyes) showed poor visual outcome. In this series studied, the principle ocular fundus change caused by dengue fever was macular hemorrhage. This may be due to the capillary changes near the macular area. But in some of the cases, the direct viral invasion and/or indirect changes of the optic nerve, the retinal pigment epithelium or photoreceptors should be considered.

Entities:  

Mesh:

Year:  1989        PMID: 2733064

Source DB:  PubMed          Journal:  Gaoxiong Yi Xue Ke Xue Za Zhi        ISSN: 0257-5655


  10 in total

1.  Multifocal electroretinography in dengue fever-associated maculopathy.

Authors:  Timothy Y Y Lai; Shaheeda Mohamed; Wai Man Chan; Ricky Y K Lai; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

Review 2.  Novel infectious agents causing uveitis.

Authors:  Moncef Khairallah; Soon Phaik Chee; Sivakumar R Rathinam; Sonia Attia; Venu Nadella
Journal:  Int Ophthalmol       Date:  2009-08-27       Impact factor: 2.031

3.  Emergent infectious uveitis.

Authors:  Moncef Khairallah; Bechir Jelliti; Salah Jenzeri
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

4.  Retinal hemorrhages in 4 patients with dengue fever.

Authors:  Maciej Piotr Chlebicki; Brenda Ang; Timothy Barkham; Augustinus Laude
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

5.  Maculopathy in dengue fever.

Authors:  Daniel Hsien-Wen Su; Soon-Phaik Chee
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

6.  Use of optical coherence tomography to evaluate visual acuity and visual field changes in dengue fever.

Authors:  Taek Kwan Rhee; Jung Il Han
Journal:  Korean J Ophthalmol       Date:  2014-01-21

7.  Massive Retinal Pigment Epithelial Detachment Following Acute Hypokalemic Quadriparesis in Dengue Fever.

Authors:  Neha Goel; Vishaal Bhambhwani; Pooja Jain; Basudeb Ghosh
Journal:  J Ophthalmic Vis Res       Date:  2016 Apr-Jun

Review 8.  Neurological Complications of Dengue Fever.

Authors:  Sweety Trivedi; Ambar Chakravarty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-21       Impact factor: 6.030

9.  Ophthalmic complications of dengue.

Authors:  David P L Chan; Stephen C B Teoh; Colin S H Tan; Gerard K M Nah; Rajesh Rajagopalan; Manjunath K Prabhakaragupta; Caroline K L Chee; Tock H Lim; Kong Y Goh
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

10.  Dengue maculopathy: visual electrophysiology and optical coherence tomography.

Authors:  Thaís Sousa Mendes; Edmundo Frota de Almeida Sobrinho; Alexandre Antonio Marques Rosa; Laiza Medeiros dos Anjos; Genilma Matos da Costa; Givago da Silva Souza; Bruno Duarte Gomes; Cézar Akiyoshi Saito; Manoel da Silva Filho; Luiz Carlos de Lima Silveira
Journal:  Doc Ophthalmol       Date:  2009-06-18       Impact factor: 1.854

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.